Maravai LifeSciences Holdings, Inc. (MRVI) vs Palvella Therapeutics, Inc. (PVLA)
- Maravai LifeSciences Holdings, Inc. MRVI 6.79 −3.96%
- Palvella Therapeutics, Inc. PVLA 120.30 −5.53%
Maravai LifeSciences Holdings, Inc. and Palvella Therapeutics, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Palvella Therapeutics, Inc. are of similar size ($1.8B and $1.8B). Palvella Therapeutics, Inc. grew revenue faster over the last twelve months: 146.7% against −5.03%. Palvella Therapeutics, Inc. has the higher net margin (0.00% vs −37.1%) and the higher return on invested capital (0.00% vs −15.8%). Across the 18 metrics below, Palvella Therapeutics, Inc. leads on 12 and Maravai LifeSciences Holdings, Inc. on 6.
Valuation
Profitability
| Metric | MRVI | PVLA | Biotechnology median |
|---|---|---|---|
| Gross margin | 34.89% | 100.00% | 65.16% |
| Operating margin | (56.08%) | 0.00% | 0.00% |
| Net margin | (37.07%) | 0.00% | 0.00% |
| Free cash flow margin | (17.17%) | 0.00% | 0.00% |
| Return on equity | (18.79%) | (46.63%) | (56.36%) |
| Return on assets | (10.31%) | (37.70%) | (48.04%) |
| Return on invested capital | (15.83%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack